4.0
May 31, 2017
Recommend
CEO approval
Business Outlook
Pros
Great set of people, products and processes. Chemours is a great turnaround story after spinning off from DuPont. Stock is on fire going up from $3.4 to $40+ in just about an year
Cons
Uncertainty with many changes right from top to bottom. M&A threat looms large